A randomized Phase II study of interleukin-2 with and without beta-interferon for patients with advanced non-small cell lung cancer: an Eastern Cooperative Oncology Group study (PZ586).

A randomized Phase II study of interleukin-2 with and without beta-interferon for patients with advanced non-small cell lung cancer: an Eastern Cooperative Oncology Group study (PZ586). Lung Cancer. 1999 Sep; 25(3):199-206.

View in: PubMed

subject areas

Adenocarcinoma
Adult
Aged
Antineoplastic Agents
Carcinoma, Non-Small-Cell Lung
Carcinoma, Squamous Cell
Drug Therapy, Combination
Female
Humans
Injections, Intravenous
Interferon-beta
Interleukin-2
Lung Neoplasms
Male
Middle Aged
Neoplasm Staging
Retrospective Studies
Survival Rate
Treatment Outcome